Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels

Immunology

Volumn 141, Issue 1, 2014, Pages 111-122

  Berahovich, Robert D ^a   Zabel, Brian A ^a   Lewén, Susanna ^a   Walters, Matthew J ^a   Ebsworth, Karen ^a   Wang, Yu ^a   Jaen, Juan C ^a   Schall, Thomas J ^a  

^a ChemoCentryx Inc   (United States)

Author keywords

Chemotaxis; CXCL12; CXCR4; CXCR7; Endothelial

Indexed keywords

CHEMOKINE RECEPTOR CXCR7; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VENULE;

CHEMOTAXIS; CXCL12; CXCR4; CXCR7; ENDOTHELIAL;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MICE; ORGAN SPECIFICITY; RECEPTORS, CXCR;

EID: 84889669040     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12176     Document Type: Article

References (56)

1. Alkhatib G. The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 2009; 4:96-103.
2. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007; 97:714-21.
3. Gelmini S, Mangoni M, Serio M, Romagnani P, Lazzeri E. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. J Endocrinol Invest 2008; 31:809-19.
4. Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008; 275:4448-55.
5. Levesque JP, Winkler IG. Mobilization of hematopoietic stem cells: state of the art. Curr Opin Organ Transplant 2008; 13:53-8.
6. Miller RJ, Banisadr G, Bhattacharyya BJ. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 2008; 198:31-8.
7. Mines M, Ding Y, Fan GH. The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr Med Chem 2007; 14:2456-70.
8. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008; 28:1950-9.
9. Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008; 267:226-44.
10. + hemangiocytes. Nat Med 2006; 12:557-67.
11. Orimo A, Gupta PB, Sgroi DC et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-48.
12. Burns JM, Summers BC, Wang Y et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203:2201-13.
13. Zabel BA, Wang Y, Lewen S et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009; 183:3204-11.
14. Luker KE, Gupta M, Steele JM, Foerster BR, Luker GD. Imaging ligand-dependent activation of CXCR7. Neoplasia 2009; 11:1022-35.
15. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010; 29:4599-610.
16. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, Lefkowitz RJ. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A 2010; 107:628-32.
17. Mahabaleshwar H, Boldajipour B, Raz E. Killing the messenger: the role of CXCR7 in regulating primordial germ cell migration. Cell Adh Migr 2008; 2:69-70.
18. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar H, Raz E, Zerwes HG, Rot A, Thelen M. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE 2010; 5:e9175.
19. Wang H, Beaty N, Chen S, Qi CF, Masiuk M, Shin DM, Morse HC. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 2012; 119:465-8.
20. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009; 113:6085-93.
21. Luker KE, Gupta M, Luker GD. Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 2009; 23:823-34.
22. Mazzinghi B, Ronconi E, Lazzeri E et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008; 205:479-90.
23. Zabel BA, Lewen S, Berahovich RD, Jaen JC, Schall TJ. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer 2011; 10:73.
24. Boldajipour B, Mahabaleshwar H, Kardash E et al. Control of chemokine-guided cell migration by ligand sequestration. Cell 2008; 132:463-73.
25. Dambly-Chaudiere C, Cubedo N, Ghysen A. Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev Biol 2007; 7:23.
26. Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, Coggins NL, Thomas DG, Luker GD. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene 2012; 31:4750-8.
27. Sanchez-Alcaniz JA, Haege S, Mueller W et al. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 2011; 69:77-90.
28. Wang Y, Li G, Stanco A et al. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 2011; 69:61-76.
29. Heesen M, Berman MA, Charest A, Housman D, Gerard C, Dorf ME. Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1. Immunogenetics 1998; 47:364-70.
30. Libert F, Parmentier M, Lefort A et al. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science 1989; 244:569-72.
31. Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol 2006; 176:2197-207.
32. Hattermann K, Held-Feindt J, Lucius R, Muerkoster SS, Penfold ME, Schall TJ, Mentlein R. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 2010; 70:3299-308.
33. Tripathi V, Verma R, Dinda A, Malhotra N, Kaur J, Luthra K. Differential expression of RDC1/CXCR7 in the human placenta. J Clin Immunol 2009; 29:379-86.
34. Neusser MA, Kraus AK, Regele H et al. The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells during renal allograft rejection. Kidney Int 2010; 77:801-8.
35. Berahovich R, Penfold ME, Schall T. Nonspecific CXCR7 antibodies. Immunol Lett 2010; 133:112-4.
36. Watanabe K, Penfold ME, Matsuda A et al. Pathogenic role of CXCR7 in rheumatoid arthritis. Arthritis Rheum 2010; 62:3211-20.
37. Berahovich RD, Wang Y, Jaen JC, Schall TJ. CXCR7 protein is not expressed on human or mouse leukocytes. J Immunol 2010; 185:5130-9.
38. O'Boyle G, Mellor P, Kirby JA, Ali S. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J 2009; 23:3906-16.
39. Balazs M, Horvath G, Grama L, Balogh P. Phenotypic identification and development of distinct microvascular compartments in the postnatal mouse spleen. Cell Immunol 2001; 212:126-37.
40. Miao Z, Luker KE, Summers BC et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A 2007; 104:15735-40.
41. Singh RK, Lokeshwar BL. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res 2011; 71:3268-77.
42. Xu H, Wu Q, Dang S et al. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS ONE 2011; 6:e27399.
43. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332:647-55.
44. Costello CM, Howell K, Cahill E et al. Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 295:L272-84.
45. Costello CM, McCullagh B, Howell K, Sands M, Belperio JA, Keane MP, Gaine S, McLoughlin P. A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease. Eur Respir J 2012; 39:1415-24.
46. + haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 2011; 37:1392-9.
47. Zhou D, Wang J, Zapala MA, Xue J, Schork NJ, Haddad GG. Gene expression in mouse brain following chronic hypoxia: role of sarcospan in glial cell death. Physiol Genomics 2008; 32:370-9.
48. Ariel A, Fredman G, Sun YP, Kantarci A, Van Dyke TE, Luster AD, Serhan CN. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 2006; 7:1209-16.
49. Cardona AE, Sasse ME, Liu L, Cardona SM, Mizutani M, Savarin C, Hu T, Ransohoff RM. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 2008; 112:256-63.
50. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354:610-21.
51. Hadley TJ, Lu ZH, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Investig 1994; 94:985-91.
52. Nibbs RJ, Kriehuber E, Ponath PD et al. The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158:867-77.
53. Madigan J, Freeman DJ, Menzies F et al. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 2010; 184:3202-12.
54. Martinez de la Torre Y, Buracchi C, Borroni EM et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007; 104:2319-24.
55. Cruz-Orengo L, Holman DW, Dorsey D et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med 2011; 208:327-39.
56. Sartina E, Suguihara C, Ramchandran S et al. Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension. Pediatr Res 2012; 71:682-8.